All In Biotech

Free tool

FAERS Monitor: Edecrin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 016092 or its brand name (Edecrin, Ethacrynic Acid). Reports on generic versions are filed under their own applications.

Reports

553

Serious

400

72% of reports

Hospitalization

224

Death reported

66

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug reaction with eosinophilia and systemic symptoms59
  • off label use52
  • nausea48
  • dyspnoea43
  • drug ineffective35
  • acute kidney injury33
  • diarrhoea33
  • drug hypersensitivity33
  • fatigue32
  • vomiting32
  • asthenia26
  • death26
  • dizziness26
  • headache25
  • weight decreased24

Reports by year received

View as table
YearReports
20048
20054
20069
20077
20089
20097
201012
201118
201231
201318
201415
201523
201627
201739
201830
201940
202028
202153
202243
202346
202425
202527
202633

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,606 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug reaction with eosinophilia and systemic symptomsSignal5987.468.74,948
acute kidney injurySignal338.25.9203
drug hypersensitivitySignal336.54.7149
weight decreasedSignal243.32.236
dyspnoeaSignal432.92.253
astheniaSignal262.61.825
vomitingSignal322.61.830
nauseaSignal482.31.836
off label useSignal522.31.737
dizziness262.01.412
diarrhoea331.91.415
fatigue321.61.16
headache251.51.04
death261.10.80
drug ineffective351.00.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.